Item Type | Name |
Concept
|
Prostate-Specific Antigen
|
Academic Article
|
5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
|
Academic Article
|
Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model.
|
Academic Article
|
Regulation of the androgen receptor by SET9-mediated methylation.
|
Academic Article
|
Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation.
|
Academic Article
|
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models.
|
Academic Article
|
Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.
|
Academic Article
|
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
|
Academic Article
|
Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
|
Academic Article
|
Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
|
Academic Article
|
ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
|
Academic Article
|
Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.
|
Academic Article
|
The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.
|
Academic Article
|
An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.
|
Academic Article
|
Identification of a cyclin d1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
|
Academic Article
|
Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo.
|
Academic Article
|
Cell-cycle dysregulation and the molecular mechanisms of prostate cancer.
|
Academic Article
|
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
|
Academic Article
|
The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.
|
Academic Article
|
CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines.
|
Academic Article
|
The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module.
|
Academic Article
|
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.
|
Academic Article
|
Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.
|
Academic Article
|
Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.
|
Academic Article
|
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
|
Grant
|
Androgen Receptor Function in Prostate Cancer
|
Academic Article
|
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
|
Academic Article
|
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.
|
Academic Article
|
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer.
|
Academic Article
|
Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line.
|
Academic Article
|
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
|
Academic Article
|
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
|